8-K: Unisys Amends Bylaws, Corrects Charter, Removes Officer Age Limit
Corporate Governance Update
Unisys Corporation announced amendments to its bylaws, including the removal of the officer age 65 term limit, and corrected an administrative error in its Certificate of Incorporation.
Summary
- The Board of Directors of Unisys Corporation approved an amendment and restatement of the company's bylaws, effective November 25, 2025.
- The bylaws were amended to remove the provision specifying that an officer's term of office shall terminate upon attaining the age of 65.
- The bylaws were also conformed to the terms of the company's corrected Certificate of Incorporation (Charter).
- A Certificate of Correction was filed on November 25, 2025, to rectify an administrative error in the Amended & Restated Certificate of Incorporation previously filed on May 9, 2025.
- The error in the Charter involved unapproved language changes in Article IV, Sections 1 and 2, which have now been reverted to their previous language.
- The Charter outlines the company's authorized stock structure, consisting of 150,000,000 shares of Common Stock and 40,000,000 shares of Preferred Stock, and details their respective rights.
- The Charter includes provisions for Junior Participating Preferred Stock (a 'poison pill'), granting holders significant dividend and voting rights (300 times common stock) and a liquidation preference.
- Strong anti-takeover provisions remain in the Charter, requiring an 80% affirmative vote of voting stock for certain business combinations with 'Interested Stockholders' unless specific conditions are met.
- The bylaws also removed the age limit for directors, which previously restricted election after age 72 (with limited extensions to 74).
- The bylaws establish Delaware state courts as the exclusive forum for certain internal corporate claims and federal district courts for Securities Act claims.
Sentiment
Score: 6
Explanation: The filing addresses routine corporate governance matters and corrects an administrative error. The removal of age limits for officers and directors is a positive for retaining talent, but the strong anti-takeover provisions could be seen as a negative for shareholder influence. Overall, it's a neutral to slightly positive update focused on internal structure rather than operational performance.
Positives
- The removal of the officer age 65 term limit allows Unisys to retain experienced management, potentially enhancing leadership continuity and leveraging institutional knowledge.
- The correction of the administrative error in the Certificate of Incorporation ensures the accuracy and legal validity of the company's foundational corporate charter.
- The removal of director age limits enables the company to retain experienced board members, potentially improving board stability and expertise.
Negatives
- The strong anti-takeover provisions, including the 80% supermajority vote for business combinations and the Junior Preferred Stock ('poison pill'), could deter potential acquirers and limit shareholders' ability to influence strategic changes or realize M&A premiums.
- The exclusive forum provisions may limit shareholder choice in legal venues for certain corporate claims.
Risks
- The anti-takeover provisions (80% vote for business combinations, Junior Preferred Stock/poison pill) could entrench current management and the board, potentially reducing accountability and limiting shareholder value creation through mergers and acquisitions.
- The exclusive forum provisions could make it more difficult or costly for shareholders to pursue certain legal claims against the company or its fiduciaries by restricting the choice of jurisdiction.
Future Outlook
NA
Management Comments
- The Board of Directors of Unisys Corporation approved an amendment and restatement of the company's bylaws to remove the provision specifying that an officer's term of office shall terminate following the attainment of the age of 65 and to conform the Amended & Restated Bylaws to the terms of the Charter.
- On November 25, 2025, the company filed with the Delaware Secretary of State a Certificate of Correction to correct its Amended & Restated Certificate of Incorporation after determining an incorrect version of the Charter was previously filed on May 9, 2025, due to an administrative error.
Industry Context
This filing primarily addresses internal corporate governance and legal compliance, rather than broader industry trends or competitive positioning. The anti-takeover provisions are common in some companies but do not reflect a universal industry trend, while the removal of age limits for officers and directors aligns with a growing corporate practice to retain experienced talent.
Comparison to Industry Standards
- The removal of age limits for officers and directors aligns with a growing trend among U.S. public companies to retain experienced leadership, moving away from mandatory retirement ages. For example, companies like IBM and General Electric have also adjusted or removed such policies to leverage institutional knowledge.
- The inclusion of strong anti-takeover provisions, such as the 80% supermajority vote for business combinations and the Junior Participating Preferred Stock (poison pill), is a common defense mechanism. While prevalent in some sectors, it can be viewed as more restrictive than the governance structures of companies like Microsoft or Apple, which generally rely on simpler majority voting for M&A.
- The adoption of Delaware as the exclusive forum for internal corporate claims is a standard practice for Delaware-incorporated companies, mirroring the approach of many large corporations due to Delaware's well-developed corporate law.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Bylaw Amendment | Removed the provision specifying that an officer's term of office shall terminate following the attainment of the age of 65. | 2025-11-25 | Allows the company to retain experienced officers beyond the previous age limit, potentially enhancing leadership continuity and leveraging institutional knowledge. |
| Bylaw Amendment | Removed the age limit for directors (previously 72, with extensions to 74). | 2025-11-25 | Enables the company to retain experienced board members, potentially improving board stability and expertise, but could also lead to less board refreshment. |
| Certificate of Incorporation Correction | Corrected an administrative error in the Amended & Restated Certificate of Incorporation filed on May 9, 2025, reverting unapproved language changes in Article IV, Sections 1 and 2 to previous language. | 2025-11-25 | Ensures the accuracy and legal validity of the company's foundational corporate charter, clarifying stock structure and rights. |
| Corporate Charter Provision | Maintained strong anti-takeover provisions, including an 80% supermajority vote requirement for certain business combinations with 'Interested Stockholders' and provisions for Junior Participating Preferred Stock (a 'poison pill'). | 2025-11-25 | Strengthens the company's defense against hostile takeovers, potentially protecting long-term strategy but also limiting shareholder ability to approve M&A transactions. |
| Bylaw Provision | Established Delaware state courts (or the federal district court for the District of Delaware) as the exclusive forum for certain internal corporate claims, and federal district courts for Securities Act claims. | 2025-11-25 | Centralizes litigation for corporate governance matters, potentially reducing legal costs and ensuring consistent application of Delaware law, but may restrict shareholder choice of forum. |
Stakeholder Impact
- Shareholders: The correction of the Charter ensures clarity on stock rights. The removal of age limits for officers and directors could lead to more stable leadership. However, the strong anti-takeover provisions might limit opportunities for M&A premiums and reduce shareholder influence on major corporate changes. Exclusive forum provisions centralize legal disputes.
- Management/Employees: Removal of officer age limits allows for continued employment and career progression for experienced individuals.
Key Dates
| Date | Description |
|---|---|
| 1984-02-22 | Original Certificate of Incorporation filed under the name Burroughs Delaware Incorporated. |
| 2011-01-01 | Commencement of annual election of directors for one-year terms (from 2011 Annual Meeting). |
| 2025-05-09 | Incorrect version of Amended & Restated Certificate of Incorporation previously filed due to administrative error. |
| 2025-11-25 | Board of Directors approved Amended & Restated Bylaws. |
| 2025-11-25 | Company filed Certificate of Correction to its Amended & Restated Certificate of Incorporation. |
| 2025-11-25 | Effective date of the Certificate of Correction and the Amended & Restated Bylaws. |
| 2025-11-28 | Date the 8-K report was signed by Debra McCann. |
Recommendation
holdThis filing primarily concerns routine corporate governance updates and the correction of an administrative error. While the removal of age limits for officers and directors is a positive for talent retention, and the anti-takeover provisions are standard for some companies, these changes are unlikely to have a material impact on the company's operational performance or financial outlook in the short term. Therefore, a 'hold' recommendation is appropriate as the filing does not present new information that would fundamentally alter the investment thesis.
Keywords
Unisys, UIS, SEC filing, 8-K, corporate governance, bylaws, certificate of incorporation, officer age limit, director age limit, anti-takeover, poison pill, business combination, Delaware law, shareholder rights, executive compensation, board of directors
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.